n-benzyladriamycin-14-valerate has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Covey, LR; Edwards, SK; Grewal, S; Liu, Y; Moore, CR; Xie, P | 1 |
1 other study(ies) available for n-benzyladriamycin-14-valerate and Disease Models, Animal
Article | Year |
---|---|
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Disease Models, Animal; Diterpenes; Doxorubicin; Enzyme Activation; Gene Expression; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Isografts; Lentivirus; Lymphoma, B-Cell; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Multiple Myeloma; Protein Kinase C-delta; Protein Transport; Proteolysis; Proto-Oncogene Proteins c-myc; TNF Receptor-Associated Factor 3; Transduction, Genetic | 2013 |